TG Therapeutics (TGTX) has shown strong upward momentum recently, with the stock price increasing by 27.75% last week following positive sales results. The stock closed at $39.23 on March 10, 2025, with a pre-market percentage change of -1.77% and a regular market gain of +2.06%.
TGTX is currently trading at $39.23, with a market cap of $6.162B. The stock has a high RSI of 85.48, indicating overbought conditions, and the MACD is showing a bullish signal but with a weakening histogram.
Recent news indicates bullish sentiment, with significant call option activity and a price target of $55 maintained by HC Wainwright. The stock has a high short interest and is approaching its earnings date on May 8, 2025.
Based on the analysis, the stock is expected to trade between $38.50 and $43.00 next week. The recommendation is to BUY on dips near the lower end of this range, targeting a breakout above $43.00.
The price of TGTX is predicted to go up 6.53%, based on the high correlation periods with AIRG. The similarity of these two price pattern on the periods is 95.06%.
TGTX
AIRG
JP Morgan
2024-11-25
Price Target
$30 → $43
Upside
+24.24%
TD Cowen
2024-10-29
Price Target
$50
Upside
+94.48%